A Clinical Grade Cell-Based Artificial APT, aAPC/mOKT3, for Unbiased Expansion of CD3+ T Lymphocytes

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-2-s3-p5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Figure 1: IHC of CD3+T Lymphocytes and CD79+B Lymphocytes in Euqine Tissues.

English

TCRαβ/CD3 Disruption Enables CD3-specific Antileukemic T Cell Immunotherapy

JCI insight
Medicine
2018English

Analysis of T Cell Receptor Variability in Tumor-Infiltrating Lymphocytes From a Human Regressive Melanoma. Evidence for in Situ T Cell Clonal Expansion.

Journal of Clinical Investigation
Medicine
1993English

Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol

Frontiers in Oncology
Cancer ResearchOncology
2013English

Human CD3+ T Lymphocytes That Express Neither CD4 Nor CD8 Antigens

Journal of Experimental Medicine
MedicineAllergyImmunology
1986English

Enrichment and Expansion With Nanoscale Artificial Antigen Presenting Cells for T Cell Adoptive Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

The T Cell Receptor/Cd3 Complex: A Dynamic Protein Ensemble

Annual Review of Immunology
AllergyImmunology
1988English

Clonal Expansion of Human T Lymphocytes Initiated by Dendritic Cells

Journal of Experimental Medicine
MedicineAllergyImmunology
1989English

T CD3+CD8+Lymphocytes Are More Susceptible for Apoptosis in the First Trimester of Normal Human Pregnancy

Journal of Immunology Research
MedicineAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy